Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-06-22, Stock:JNJ, The news for the past five days is as follows:
2018-06-15: NEWS1: LifeScan Global Corporation -- Moody's downgrades LifeScan Global's term loan B rating to B2 from B1.NEWS2: 7 Perfect Dividend Stocks.NEWS3: 7 Perfect Dividend Stocks.NEWS4: 10 Best Stocks to Buy and Hold Forever.NEWS5: 10 Best Stocks to Buy and Hold Forever.NEWS6: [$$] Can Investment Performance Be Predicted?.NEWS7: Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III.NEWS8: Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III.NEWS9: 7 Perfect Dividend Stocks.NEWS10: Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health.NEWS11: Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health.NEWS12: Dow 30 Stock Roundup: Caterpillar Raises Dividend, Merck's Keytruda Gets FDA Nod.NEWS13: Dow 30 Stock Roundup: Caterpillar Raises Dividend, Merck's Keytruda Gets FDA Nod.NEWS14: Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III.NEWS15: Dow 30 Stock Roundup: Caterpillar Raises Dividend, Merck&apos;s Keytruda Gets FDA Nod.NEWS16: Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health.NEWS17: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS18: Estimating The Fair Value Of Johnson & Johnson (NYSE:JNJ).NEWS19: Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed..NEWS20: Growth & Income Buys | Johnson & Johnson and International Paper.NEWS21: Growth & Income Buys | Johnson & Johnson and International Paper.
2018-06-18: NEWS1: Cramer floats idea for 'gloomy' ETF with Wall Street's mo....NEWS2: Cramer floats idea for 'gloomy' ETF.NEWS3: Markets Right Now: Stocks look to recover from early skid.NEWS4: After split from Actelion, Idorsia CEO plans to raise more cash in 2019.NEWS5: Why Geron Corporation Stock Is Heading Higher Today.NEWS6: Why Geron Corporation Stock Is Heading Higher Today.NEWS7: FOCUS-After split from Actelion, Idorsia CEO plans to raise more cash in 2019.NEWS8: Why Bristol-Myers Squibb is a Top Socially Responsible Dividend Stock (BMY).NEWS9: Why Bristol-Myers Squibb is a Top Socially Responsible Dividend Stock (BMY).NEWS10: Why Geron Corporation Stock Is Heading Higher Today.NEWS11: FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio.NEWS12: UNF, Mayo experiment with rare 3-D microscope.NEWS13: Johnson & Johnson Vision: FDA Approves IDESIGN Refractive Studio - Quick Facts.NEWS14: Johnson & Johnson Vision: FDA Approves IDESIGN Refractive Studio - Quick Facts.
2018-06-19: NEWS1: What’s the Latest on Teva’s Fremanezumab?.NEWS2: The Charts and Indicators on Johnson & Johnson Are Still Mostly Bearish.NEWS3: Opioid Ruling Could Send  Purdue, Drugmakers to Court.NEWS4: ITOT, JPM, XOM, JNJ: Large Inflows Detected at ETF.NEWS5: ITOT, JPM, XOM, JNJ: Large Inflows Detected at ETF.NEWS6: Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results.NEWS7: 3 Stocks That Are Absurdly Cheap Right Now.NEWS8: 3 Stocks That Are Absurdly Cheap Right Now.NEWS9: 3 Stocks That Are Absurdly Cheap Right Now.NEWS10: FOCUS-After split from Actelion, Idorsia CEO plans to raise more cash in 2019.NEWS11: Alliance Pharma To Buy Rights To J&J's Nizoral In APAC For Â£60 Mln; Stock Up.NEWS12: Alliance Pharma To Buy Rights To J&J's Nizoral In APAC For Â£60 Mln; Stock Up.NEWS13: CSBR Up 36% This Month, ZIOP Hit By Clinical Hold, Watch Out For SRPT Today.NEWS14: CSBR Up 36% This Month, ZIOP Hit By Clinical Hold, Watch Out For SRPT Today.
2018-06-20: NEWS1: How Johnson & Johnson’s Valuation Compares.NEWS2: A Look at Johnson & Johnson’s Stock Performance.NEWS3: What Analysts Recommend for Johnson & Johnson Stock.NEWS4: A Look at Allergan’s Valuation as of June 19.NEWS5: Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks.NEWS6: Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks.NEWS7: Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks.NEWS8: Here’s how much Houston public companies spent on litigation in 2017.
2018-06-21: NEWS1: Crowning Achievement: Six Dividend Kings With 50+ Years of Rising Dividends.NEWS2: Crowing Achievement: Six Dividend Kings With 50+ Years of Rising Dividends.NEWS3: Johnson & Johnson Releases Positive Study Data for Oncology Drug.NEWS4: Johnson & Johnson Receives Offer to Divest Sterilization Business.NEWS5: Johnson & Johnson Accepts Sale of Its LifeScan Business.

Answer: Rise